MedPath

Effects of transcranial direct current electrical stimulation on major depressive disorder

Phase 2
Recruiting
Conditions
Major depressive disorder
Registration Number
JPRN-jRCTs052220086
Lead Sponsor
Omori M Ichiro
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

The inclusion criteria are as follows:
1) Inpatients in the department of psychiatry of the University of Fukui Hospital
2) Male or female patients between 25 and 90 years of age
3) Diagnosed major depressive disorder according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5; American Psychiatric Association)
4) Moderate to severe depressive state according to the Hamilton Depression Rating Scale (score <= 17)
5) Patients provides written informed consent prior to initiation of any study procedures

Exclusion Criteria

Exclusion criteria
1) Past or current diagnosis of schizophrenia, schizoaffective disorder, bipolar I disorder and bipolar II disorder
2) Presence of severe physical diseases or in the terminal phase of the disease
3) Under treatment for thyroid function abnormality
4) With abnormal EEG findings
5) With intracranial space-occupying lesion
6) pregnancy
7) Need to be cured urgently due to severe depressive state with inability take any food and/or severe suicidal ideation
8) Lack of cooperation regarding 20-minutes procedure of tDCS due to severe agitation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) The primary efficacy outcomes are the changes from baseline in symptom rationg scale, including Hamilton Depression Rating Scale (HAMD-17), the Mental and Physical Ques tionnaire (PHQ), and the Beck Depression Questionnaire, Second Edition (BDI-II)<br>2) Safety is evaluated by evaluated by Proposal of a questionnaire surveying for tDCS adverse effects (PQSTAE)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath